CDC Guidance: Immunocompromised may need a fourth Covid-19 shot.
Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States – Centers for Disease Control and Prevention Commentaries: Immunocompromised may need a fourth Covid-19 shot, CDC says – CNN Some immunocompromised people can receive a 4th Covid shot, CDC says – NBC News
The post CDC Guidance: Immunocompromised may need a fourth Covid-19 shot. appeared first on Links Medicus.
Observational study showed J&J single shot vaccine had an effectiveness of 74% against symptomatic Covid-19.
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19 – JAMA Network Open Commentaries: Single-Dose Ad26.COV2.S Vaccine—Room for Improvement – JAMA Network Open Real-world study shows J&J COVID-19 vaccine 74% effective – CIDRAP Related: J&J COVID-19 Vaccine: FDA recommends booster shot for all adults aged 18 and older at least two […]
The post Observational study showed J&J single shot vaccine had an effectiveness of 74% against symptomatic Covid-19. appeared first on Links Medicus.
RCT: Among children with community-acquired pneumonia discharged within 48 hours from the ED or hospital, lower-dose outpatient oral amoxicillin was noninferior to a higher dose, and a 3-day duration course was noninferior to 7 days.
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA (free for a limited period) Related: RCT: 5 days of high-dose amoxicillin therapy noninferior to 10 days for the treatment of pediatric community-acquired pneumonia Randomized Trial: Amoxicillin for 3 Days […]
The post RCT: Among children with community-acquired pneumonia discharged within 48 hours from the ED or hospital, lower-dose outpatient oral amoxicillin was noninferior to a higher dose, and a 3-day duration course was noninferior to 7 days. appeared first on Links Medicus.
Review: The role of chest imaging in the diagnosis, management, and monitoring of Covid-19.
The role of chest imaging in the diagnosis, management, and monitoring of coronavirus disease 2019 (COVID-19) – Insights into Imaging
The post Review: The role of chest imaging in the diagnosis, management, and monitoring of Covid-19. appeared first on Links Medicus.
Consensus Statement: Preoperative management of gastrointestinal and pulmonary medications.
Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement – Mayo Clinic Proceedings Related articles from Mayo Clinic Proceedings: Consensus Statement: Preoperative management of endocrine, hormonal, and urologic medications Consensus statement: Preoperative management of opioid and nonopioid analgesics Perioperative evaluation and management of patients with diabetes, thyroid […]
The post Consensus Statement: Preoperative management of gastrointestinal and pulmonary medications. appeared first on Links Medicus.
Study shows fully vaccinated individuals can still catch SARS-CoV-2 delta variant and efficiently transmit infection in household settings, including to fully vaccinated contacts.
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study – The Lancet Infectious Diseases Commentaries: COVID vaccines effective but household transmission of delta a risk for 1 in 4 – Imperial College London What is the vaccine effect on […]
The post Study shows fully vaccinated individuals can still catch SARS-CoV-2 delta variant and efficiently transmit infection in household settings, including to fully vaccinated contacts. appeared first on Links Medicus.
Imaging of congenital lung diseases presenting in the adulthood: a pictorial review.
Imaging of congenital lung diseases presenting in the adulthood: a pictorial review – Insights into Imaging
The post Imaging of congenital lung diseases presenting in the adulthood: a pictorial review. appeared first on Links Medicus.
Study suggests smoking cessation, but not reduction, is associated with reduced risk of cardiovascular disease.
Smoking cessation, but not reduction, reduces cardiovascular disease incidence – European Heart Journal (link to abstract – $ for full-text) Commentary on Twitter May I just reduce the number of cigarettes? New study shows this is not enough! Smoking cessation, but not reduction, was associated with cardiovascular disease incidence drop.https://t.co/lVgXMwavNs#smoke, #cigarettes, #MI, #cardiotwitter, @ESC_Journals, […]
The post Study suggests smoking cessation, but not reduction, is associated with reduced risk of cardiovascular disease. appeared first on Links Medicus.
CDC Study: COVID-19 vaccine associated with 5 times the protection of ‘natural immunity’.
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 – CDC Morbidity and Mortality Weekly Report Commentaries: COVID-19 vaccine gives 5 times the protection of ‘natural immunity,’ data show – CIDRAP COVID shots more protective than past infection, study shows – Associated Press […]
The post CDC Study: COVID-19 vaccine associated with 5 times the protection of ‘natural immunity’. appeared first on Links Medicus.
Observational study suggests a third dose of the Pfizer COVID-19 vaccine can prevent severe COVID-19-related outcomes, compared with only two doses received at least 5 months before.
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study – The Lancet Invited Commentary: Boosters appear effective, but are they always needed? – The Lancet Commentaries on Twitter Nice analysis of boosters in @TheLancet Fri.: https://t.co/KqXInFa3a9 But I want to highlight one number: […]
The post Observational study suggests a third dose of the Pfizer COVID-19 vaccine can prevent severe COVID-19-related outcomes, compared with only two doses received at least 5 months before. appeared first on Links Medicus.